サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1574938

創薬における人工知能市場：疾患タイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Artificial Intelligence in Drug Discovery Market, By Disease Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 316 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
創薬における人工知能市場：疾患タイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 316 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

創薬における人工知能市場規模は2023年に15億9,043万米ドルとなり、2024年から2032年にかけてCAGR 29.90%で拡大

創薬における人工知能市場-市場力学

より迅速なドラッグデリバリーへのニーズの高まりとビッグデータ、機械学習の進歩が市場需要を促進する見込み

COVID-19パンデミックは、より迅速な医薬品開発の緊急ニーズを浮き彫りにしました。膨大なデータセットを迅速に選別し、分子の相互作用を予測し、潜在的な薬剤候補を特定するAIの能力は、大きな推進力となっています。製薬会社は、特に緊急の健康危機やアンメット・メディカル・ニーズに対して、新薬の市場投入までの時間を短縮する必要に迫られており、AIは魅力的なソリューションとなっています。従来の創薬は非常にコストがかかり、新薬の上市には26億米ドル以上のコストと10～15年の時間がかかると試算されています。AIは、ターゲット同定、リード探索、臨床試験などのプロセスを合理化することで、こうしたコストを大幅に削減する可能性を提供します。作業を自動化し、実験の失敗を減らすことで、AIは製薬会社の経済的負担を軽減することができます。こうしたメリットは、市場の需要を高めると予想されます。

ヘルスケアと製薬業界は、ゲノム、プロテオミクス、臨床試験、実世界のエビデンス（電子カルテなど）から大量のデータを生成します。AIは大規模なデータセットで繁栄し、予測分析や隠れたパターンの特定を可能にします。生物学的・化学的情報を含む高品質のヘルスケアデータの利用可能性が高まっていることが、創薬におけるAIの有効性を後押ししています。深層学習、強化学習、自然言語処理（NLP）などのAI技術の急速な進歩により、創薬に使用されるAIモデルの精度と効率が向上しています。

創薬における人工知能市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約29.90%のCAGRで毎年成長すると推定されます。

疾患タイプ別セグメンテーションに基づくと、予測手段を必要とする治療患者からの高い需要により、2023年には腫瘍学セグメントが最大の市場シェアを示すと予測されました。

用途別では、急速な研究開発活動により、薬剤最適化・再利用分野が2023年の主要用途分野となった。

エンドユーザー別では、製薬企業による研究開発投資の増加により、研究機関が2023年の主要エンドユーザーでした。

地域別では、AI技術の進歩により、北米が2023年の主要収益源でした。

創薬における人工知能市場-セグメンテーション分析：

創薬における人工知能の世界市場は、疾患タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

疾患タイプ別では、がん、心血管疾患、感染症、代謝性疾患、その他の5つに分類されます。市場を独占しているのは腫瘍分野です。がんの有病率の増加と効果的な治療が可能であることが市場の成長を後押ししています。

市場は用途別に3つのカテゴリーに分類される：薬剤最適化・再利用、前臨床試験、その他。薬剤最適化・再利用分野が市場を独占しています。前臨床試験セグメントは予測期間中に大きな成長が見込まれます。

市場はエンドユーザー別に、研究機関、臨床ラボ、その他の4つに分類されます。研究機関セグメントは市場を独占しており、予測期間中も高い優位性を維持すると予測されています。製薬企業による創薬への投資が増加していることが、市場の需要に拍車をかけています。

創薬における人工知能市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。北米は現在、創薬における人工知能（AI）の最大市場であり、主に米国市場の成長に牽引されています。北米には、AIや創薬プロジェクトに多額の資金が投入されるとともに、一流の学術機関や研究機関を擁する強力な調査インフラがあります。欧州は、創薬におけるAIの第2位の市場です。同地域は、強固なヘルスケア・インフラと製薬会社とAI企業の積極的な協力関係により、急速な普及が見られます。

創薬における人工知能市場-競合情勢：

創薬における人工知能（AI）市場は競争が激しくダイナミックであり、大手製薬企業からAI主導の新興企業まで数多くの企業がAI技術に積極的に投資しています。各社は、優れた予測精度、分子設計の効率性、既存の製薬研究開発システムとの統合機能を提供する独自のAIモデルを開発することでしのぎを削っています。各社は、AIを創薬だけでなく臨床試験にも応用し、患者募集の最適化、転帰の予測、試験期間とコストの削減に活用しています。

2023年、ロシュとエクスクエンティアは、新規創薬ターゲットの同定にAIを活用するための提携を結びました。

2022年、サノフィはAI企業オウキンとの提携に1億米ドル以上を投資し、腫瘍学研究にAIプラットフォームを活用します。

2023年、インシリコ・メディシンはAI創薬プラットフォームを拡大するため、2億5,500万米ドルの資金提供を受けた。

目次

第1章 創薬市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 創薬における人工知能市場の主要動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 創薬における人工知能の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 創薬における人工知能市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 創薬市場情勢

  • 創薬における人工知能市場の分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 創薬における人工知能市場- 疾患タイプ別

  • 概要
    • 疾病タイプ別セグメントシェア分析
    • 腫瘍学
    • 心血管疾患
    • 感染症
    • 代謝性疾患
    • その他

第8章 創薬における人工知能市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 医薬品の最適化と再利用
    • 前臨床試験
    • その他

第9章 創薬における人工知能市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 調査機関
    • 臨床検査室
    • その他

第10章 創薬における人工知能市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-創薬産業における人工知能

  • 競合ダッシュボード
  • 企業プロファイル
    • Insilico Medicine
    • Atomwise
    • Exscientia
    • BenevolentAI
    • Schrodinger
    • XtalPi
    • Recursion Pharmaceuticals
    • Cyclica
    • Valo Health
    • IBM Watson Health
    • Deep Genomics
    • Bayer AG
    • Roche
    • Pfizer
    • Sanofi
    • AstraZeneca
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV3937

REPORT HIGHLIGHT

Artificial Intelligence in Drug Discovery Market size was valued at USD 1,590.43 Million in 2023, expanding at a CAGR of 29.90% from 2024 to 2032.

Artificial Intelligence (AI) in drug discovery is the application of machine learning (ML), deep learning, and other AI techniques to accelerate and improve the process of discovering new drugs. Traditionally, drug discovery is a lengthy, costly, and labor-intensive process that can take more than a decade to bring a new drug to market. AI seeks to enhance various stages of this process by providing faster insights, automating tasks, and reducing costs.

Artificial Intelligence in Drug Discovery Market- Market Dynamics

Growing need for faster drug delivery and advancement in big data, machine learning is expected to propel market demand

The COVID-19 pandemic highlighted the urgent need for faster drug development. AI's ability to quickly sift through vast datasets, predict molecule interactions, and identify potential drug candidates is a major driver. Pharmaceutical companies are under pressure to accelerate time-to-market for new therapies, especially for urgent health crises or unmet medical needs, making AI an attractive solution. Traditional drug discovery is extremely costly, with estimates that bringing a new drug to market can cost over $2.6 billion and take 10-15 years. AI offers the potential to significantly reduce these costs by streamlining processes such as target identification, lead discovery, and clinical trials. By automating tasks and reducing experimental failures, AI can lower the financial burden on pharmaceutical companies. These benefits are expected to bolster the market demand.

The healthcare and pharmaceutical industries generate massive amounts of data from genomics, proteomics, clinical trials, and real-world evidence (e.g., electronic health records). AI thrives on large datasets, enabling predictive analytics and identifying hidden patterns. The growing availability of high-quality healthcare data, including biological and chemical information, fuels AI's effectiveness in drug discovery. Rapid progress in AI techniques such as deep learning, reinforcement learning, and natural language processing (NLP) has improved the accuracy and efficiency of AI models used in drug discovery.

Artificial Intelligence in Drug Discovery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 29.90% over the forecast period (2024-2032)

Based on Disease Type segmentation, the oncology segment was predicted to show maximum market share in the year 2023, owing to high demand from therapeutic patients requiring predictive measures.

Based on Application segmentation, drug optimization & repurposing segment was the leading Application segment in 2023, due to the rapid R&D activities.

Based on End User segmentation, research institutes segment was the leading End User segment in 2023, due to increasing investment by pharma companies in R&D.

On the basis of region, North America was the leading revenue generator in 2023, due to the advancement in AI technologies.

Artificial Intelligence in Drug Discovery Market- Segmentation Analysis:

The Global Artificial Intelligence in Drug Discovery Market is segmented on the basis of Disease Type, Application, End User, and Region.

The market is divided into five categories based on Disease Type: oncology, cardiovascular diseases, infectious diseases, metabolic diseases, and others. The oncology segment dominates the market. The increasing prevalence of cancer and effective treatment available is boosting market growth.

The market is divided into three categories based on Application: drug optimization & repurposing, preclinical testing, and others. The drug optimization & repurposing segment dominates the market. The preclinical testing segment is expected to grow at significant rate over the forecast period.

The market is divided into four categories based on End User: research institutes, clinical laboratories, and others. The research institutes segment dominates the market and is expected to maintain its high dominance during the forecast period. The rising number of investments by pharma companies in drug discoveries is spurring market demand.

Artificial Intelligence in Drug Discovery Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is currently the largest market for AI in drug discovery, primarily driven by the growing United States market. North America has a strong R&D infrastructure with leading academic institutions and research organizations, along with significant funding for AI and drug discovery projects. Europe is the second-largest market for AI in drug discovery. The region is witnessing rapid adoption due to robust healthcare infrastructure and active collaboration between pharmaceutical companies and AI firms.

Artificial Intelligence in Drug Discovery Market- Competitive Landscape:

The Artificial Intelligence (AI) in the Drug Discovery market is highly competitive and dynamic, with numerous companies ranging from established pharmaceutical giants to AI-driven startups actively investing in AI technologies. Companies are competing by developing unique AI models that offer superior prediction accuracy, efficiency in molecule design, and integration capabilities with existing pharma R&D systems. Companies are extending AI applications beyond drug discovery into clinical trials, using AI to optimize patient recruitment, predict outcomes, and reduce trial duration and costs.

In 2023, Roche and Exscientia have formed a collaboration to leverage AI in the identification of novel drug targets.

In 2022, Sanofi invested over $100 million in a partnership with AI firm Owkin to leverage its AI platform for oncology research.

In 2023, Insilico Medicine received USD 255 million in funding to scale up its AI drug discovery platform.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET KEY PLAYERS

  • Insilico Medicine
  • Atomwise
  • Exscientia
  • BenevolentAI
  • Schrodinger
  • XtalPi
  • Recursion Pharmaceuticals
  • Cyclica
  • Valo Health
  • IBM Watson Health
  • Deep Genomics
  • Bayer AG
  • Roche
  • Pfizer
  • Sanofi
  • AstraZeneca
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Oncology
  • Cardiovascular diseases
  • Infectious diseases
  • Metabolic diseases
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Drug optimization & repurposing
  • Preclinical testing
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Research Institutes
  • Clinical Laboratories
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Artificial Intelligence in Drug Discovery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Artificial Intelligence in Drug Discovery Market Snippet by Disease Type
    • 2.1.2. Artificial Intelligence in Drug Discovery Market Snippet by Application
    • 2.1.3. Artificial Intelligence in Drug Discovery Market Snippet by End User
    • 2.1.4. Artificial Intelligence in Drug Discovery Market Snippet by Country
    • 2.1.5. Artificial Intelligence in Drug Discovery Market Snippet by Region
  • 2.2. Competitive Insights

3. Artificial Intelligence in Drug Discovery Key Market Trends

  • 3.1. Artificial Intelligence in Drug Discovery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Artificial Intelligence in Drug Discovery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Artificial Intelligence in Drug Discovery Market Opportunities
  • 3.4. Artificial Intelligence in Drug Discovery Market Future Trends

4. Artificial Intelligence in Drug Discovery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Drug Discovery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Artificial Intelligence in Drug Discovery Market Landscape

  • 6.1. Artificial Intelligence in Drug Discovery Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Drug Discovery Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 7.1.2. Oncology
    • 7.1.3. Cardiovascular diseases
    • 7.1.4. Infectious diseases
    • 7.1.5. Metabolic diseases
    • 7.1.6. Others

8. Artificial Intelligence in Drug Discovery Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Drug optimization & repurposing
    • 8.1.3. Preclinical testing
    • 8.1.4. Others

9. Artificial Intelligence in Drug Discovery Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Research Institutes
    • 9.1.3. Clinical Laboratories
    • 9.1.4. Others

10. Artificial Intelligence in Drug Discovery Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Artificial Intelligence in Drug Discovery Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Artificial Intelligence in Drug Discovery Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Artificial Intelligence in Drug Discovery Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Artificial Intelligence in Drug Discovery Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Artificial Intelligence in Drug Discovery Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Artificial Intelligence in Drug Discovery Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Insilico Medicine
    • 11.2.2. Atomwise
    • 11.2.3. Exscientia
    • 11.2.4. BenevolentAI
    • 11.2.5. Schrodinger
    • 11.2.6. XtalPi
    • 11.2.7. Recursion Pharmaceuticals
    • 11.2.8. Cyclica
    • 11.2.9. Valo Health
    • 11.2.10. IBM Watson Health
    • 11.2.11. Deep Genomics
    • 11.2.12. Bayer AG
    • 11.2.13. Roche
    • 11.2.14. Pfizer
    • 11.2.15. Sanofi
    • 11.2.16. AstraZeneca
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us